Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately owned biopharma company, today announced its receipt of Health Canada’s approval for the standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations. According to the update, the licenses are effective as of Nov. 20, 2020. Valid for a three-year period, the terms of the licenses include approval of a single-story production facility designed to support micropropagation tissue culture, organic cultivation, processing and medical sales requirements. Phase II plans include expansion of the research laboratory and controlled cultivation rooms, as well as the addition of a medical dispensary.
To view the full press release, visit https://nnw.fm/VOVtJ
About Way2Grow Nurseries (“W2G”)
Way2Grow is a privately owned company in the cannabis industry. W2G began with an organic vision to help patients gain better access to high quality, consistent, organic botanical and pharmaceutical products. To achieve this vision, W2G developed a consistent phyto-pharmaceutical feedstock growth plan through the use of tissue culture and molecular biology. These methods allow for the standardization of the procedures used to ensure quality and consistency of W2G botanicals and future pharmaceuticals.
W2G’s extensive research and IP approach is focused on the development of several new plant-based cultivation techniques, hybrid cultivar development, genetic profiling and tissue culture. By developing a molecular breeding and genetics program, W2G can identify new bioactive compounds to determine interactions with specific genes responsible for chronic diseases. Way2Grow is located in Osoyoos, British Columbia, and is regulated under the Cannabis Act and the Cannabis Regulations (Canada).
For more information, visit the company’s website at www.W2G.ca.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
